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Background: Left ventricular hypertrabeculation/noncompaction (LVHT) is a cardiac abnormality of unknown
etiology which has been described in children as well as in adults with and without chromosomal aberrations.
LVHT has been reported in association with various cardiac and extracardiac abnormalities like epilepsy and facial
dysmorphism.
Case presentation: A unique combination of LVHT, atrial septal defect, pulmonary valve stenosis, aortic stenosis,
epilepsy and minor facial anomalies is presented in a 5.5 years old girl. Microarray-based genomic hybridization
(array-CGH) detected six previously not described copy number variants (CNVs) inherited from a clinically unaffected
father and minimally affected mother, thus, most likely, not clinically significant but rare benign variants.
Conclusions: Despite this complex phenotype de novo microdeletions or microduplications were not detected by
array CGH. Further investigations, such as whole exome sequencing, could reveal point mutations and small indels
as the possible cause.
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Left ventricular hypertrabeculation/noncompaction (LVHT)
is a cardiac abnormality of unknown etiology which has
been described in children as well as in adults. LVHT has
been reported in association with various cardiac abnor-
malities, like Ebstein anomaly, pulmonary stenosis or
atrial septal defect [1-12]. LVHT is associated with sev-
eral extracardiac, especially neurological, abnormalities.
LVHT has been reported in association with epilepsy, fa-
cial dysmorphism or minor anomalies [1,4,12-18]. Sev-
eral chromosomal aberrations have been identified in
LVHT associated with heart defects [1,4,8,10,12,15-17].
We present a pediatric patient with LVHT and other
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reproduction in any medium, provided the oranomalies in whom microarray-based comparative gen-
omic hybridization (array CGH) detected new copy num-
ber variants (CNVs).Case presentation
A 5.5-year old girl had undergone surgical patch closure
of a large secundum atrial septal defect with valvotomy
of a moderate pulmonary stenosis at the age of 2 months;
a mild aortic stenosis with a thickened tricuspid aortic
valve was not corrected. She was born as the first child
to non-consanguineous parents. The family history was
negative for sudden cardiac death, but the maternal grand-
father had epileptic seizures without fever in his youth. At
the age of 12 months the girl suffered from a first afebrile
seizure and at the age of 23 months from a first febrile
seizure. Four months later she suffered from a series of
afebrile seizures. Therefore valproic acid was started and
maintained for 2 years. During this treatment she wastd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Frontal pictures of the patient showing bilateral
epicanthic folds, broad eyebrows, broad nasal tip and
hypertelorism.
Figure 2 Lateral pictures of the patient showing bilateral
epicanthic folds, broad eyebrows, broad nasal tip and
hypertelorism.
Figure 3 Echocardiographic apical 4-chamber-view showing the
hypertrabeculated left ventricular apex with a two-layered
structure.
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After tapering valproic acid over a period of 2 months,
short generalized paroxysmal discharges appeared on the
EEG for the first time without clinical correlate. One
year later she suffered from two further uncomplicated
febrile seizures. Since then she is seizure-free without
anticonvulsive treatment but the 24 h-EEG persistently
shows subclinical absences. Since the intellectual and
physical development of the patient is normal it was
decided together with the parents not to restart the anti-
epileptic medication but to follow her up closely. Cere-
bral magnetic resonance imaging was normal. Clinical
cardiologic, echocardiographic and neurologic examina-
tions of the first degree relatives were normal except for
the mother who showed epicanthic folds and hypertelor-
ism. Unfortunately, the maternal grandfather did not
consent with any investigations.Figure 4 Using colour-Doppler-sonography the intertrabecular
recesses are perfused from the ventricular cavity.
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eyebrows, a broad nasal tip and hypertelorism, however
no ptosis or low-set ears (Figures 1 and 2). Her body
weight was 18 kg (25th percentile), head circumference
51 cm (50th percentile) and height 115 cm (75th percent-
ile). She did not complain about any cardiac symptoms
and did not suffer from heart failure. Twelve-lead electro-
cardiogram showed normal sinus rhythm alternating with
an atrio-ventricular-nodal rhythm and an incomplete
right-bundle-branch-block. Twenty-four-hour electrocar-
diogram showed sporadic ventricular and supraventric-
ular ectopic beats. Echocardiography revealed a mild
residual valvular pulmonary stenosis with moderate pul-
monary valve regurgitation and mild aortic valve stenosis
with mild aortic regurgitation. Left ventricular function
was normal, however, extensive hypertrabeculation re-
sulting in a two-layered structure of the myocardium was
visible in the mid-ventricular and apical segments of
the left ventricle, consistent with the diagnosis of LVHT
(Figures 3 and 4). Review of previous echocardiographic
examinations disclosed that LVHT had been present
already at age 2 years. As a primary prophylaxis for
cardiac embolism aspirin 50 mg/d was started. Since
she was symptom-free, no further cardiac medication
was prescribed. At the latest follow-up investigation in
September 2011, she was in a good cardiac and neuro-
logic condition, no seizures had recurred and her intel-
lectual development was normal. Echocardiography was
unchanged.
Molecular genetic analyses of the PTPN11, KRAS, RAF1
and SOS1 genes were negative. Array CGH using a 1 M
oligonucleotide microarray platform (Agilent Technolo-
gies, Santa Clara, CA) was performed to screen genome-Table 1 Array CGH detected CNVs
Chromosomal band CNV Start End
1p12 del 120338195 120404356
1q42.3 del 234409418 234422919
3q26.32q26.33 dup 180445165 180668097
14q32.11 dup 89942827 90019073
20q13.33 del 59412001 59460188
20q13.33 dup 59597204 59629701
Positions according to hg18.wide for submicroscopic deletions and duplications [19].
Genomic positions are given according to genome-build
hg18. Array CGH detected five previously not described
CNVs as listed in Table 1. FISH analyses were not carried
out because of the size of the CNVs. Regarding the dupli-
cations it could not be assessed whether they were
tandem-duplications on the same locus or whether the
duplicated fragment was inserted or translocated in an-
other chromosome. By application of quantitative Real-
Time PCR (qPCR) we could show, however, that none of
the changes had developed de novo. All five CNVs are
currently not listed in the Toronto Database of Genomic
Variants (DGV), therefore, have to be considered as non-
frequent variants in normal controls. Follow-up and test-
ing of the index patient and her parents by qPCR
revealed that all CNVs were inherited from one of the
unaffected parents (maternal: deletion 1q42.3, duplica-
tion 3q26.32q26.33; paternal: duplication 14q32.11, dele-
tion and duplication 20q13.33). We thus conclude that
these changes are most likely not clinically significant
CNVs but rare benign variants, although a reduced pene-
trance of inherited CNVs cannot be excluded.
Discussion
LVHT associated with atrial septal defect with or without
pulmonary valve stenosis has been reported by several
authors [2-9,11]. In most of these patients atrial septal
defect and LVHT were associated with several other car-
diac and extracardiac anomalies, and genetic studies
revealed various mutations as listed in Table 2. However,
the combination of a secundum type atrial septal defect
with pulmonary stenosis and aortic stenosis in combin-
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Table 2 Reports about left ventricular noncompaction/hypertrabeculation with atrial septal defect
Ref. Age/sex Additional cardiac findings Extracardiac comorbidity Follow-up Genetic findings
[2] 39y/f Eb, heart failure, EF <55 NI NI MYH7 mutation










[10] NI/m AV-block I,
syncope
NI NI NKX2.5 mutation
[11] 23y/m VSD NI NI NI










[5] 16y/m None NI NI E101K ACTC mutation
[5] 62y/m None NI NI E101K ACTC mutation




[7] 5d/m EF <55, PDA, Eb NI Alive NI
[7] 1d/f None Ni Alive NI
[7] 6 m/m Ectopic atrial rhythm, VSD NI Alive NI
[7] 5y/f WPW, Eb NI Alive NI
[7] 6 m/f EF <55, VSD, SAS, Coa NI Dead NI
[7] 2 m/m VSD NI Alive NI
[7] 1 m/f SVT, VT, VSD, PDA, DILV NI Alive NI
[7] Birth/f EF <55, PDA NI Dead NI
[7] 1d/f VSD, PDA, BAV, LSVC NI Alive NI
[7] 9 m/f EF <55, VSD NI Dead NI
[7] 2d/m EF <55, VSD NI Dead NI
[7] 3 m/m VSD NI Alive NI
[7] 6d/m EF <55 NI Alive NI
[7] 9 m/m VSD NI Alive NI
[7] 7d/f EF <55 NI Alive NI
[7] 1 m/m EF <55 NI Alive NI
[8] Birth/f Sinusbradycardia,
pulmonary valve atresia
BLI, ACV, abdominal situs
ambiguous, polysplenia
Dead Linkage to 6p24.3-21.2
[8] 22y/m Sinusbradycardia, AF BLI, ACV Alive Linkage to 6p24.3-21.2
[8] 32y/f Pulmonary valve stenosis,
sick sinus syndrome
ACV, polysplenia,
malrotation of the gut
Alive Linkage to 6p24.3-21.2
[8] 59y/m AF, heart failure, EF <55 Polysplenia Died suddenly Linkage to 6p24.3-21.2
NI, not indicated; EF, <55 left ventricular ejection fraction <55 %; PDA, patent ductus arteriosus; Eb, Ebstein anomaly of the tricuspid valve; VSD, ventricular septal
defect; WPW, Wolff-Parkinson-White; SAS, subaortic stenosis; Coa, coarctation of the aorta; SVT, supraventricular tachycardia; VT, ventricular tachycardia; DILV,
double-inlet left ventricle; BAV, bicuspid aortic valve; LSVC, left-sided superior vena cava; ACV, azygous continuation of the vena cava inferior; AF, atrial fibrillation;
BLI, bronchial left isomerism.
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with monosomy 1p36 [1,15,16] and interstitial 1q43 dele-
tion [4]. Facial anomalies and LVHT have been described
previously in children with developmental impairment,
interstitial 1q43 deletion [4], deletion 1p36 syndrome [1],
interstitial 8p23.1 deletion [12], point mutations and de-
letions of theNSD1 gene located at chromosome 5q35 [17]and in an adult with sex chromosome mosaicism, male
phenotype and the karyotype mos45,X(28)/46,X,+mar
(21)/47,X, + 2 mar(1) [18].
CNVs are structural genomic variants due to deletions
or duplications, resulting in a copy-number change of
the respective genomic region. CNVs may include entire
genes, regions of transcribed sequence, or nontranscribed
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gene can be expected to have an effect on gene dosage,
the consequences of CNVs in nontranscribed sequences
are less clear [20]. According to the resolution of the
applied array platform (5–10 kb genome-wide) we cur-
rently do not have evidence for a clinically relevant chro-
mosomal imbalance i.e. gain or loss of genomic material.
However, it is still possible that an underlying chromo-
somal abnormality either below the detection limit of
the array or a balanced rearrangement which is unde-
tectable by array CGH is causative for the described
phenotype. This assumption is supported by the previ-
ously reported chromosomal defects in LVHT associated
with facial anomalies, atrial septal defect and epilepsy.
The presence of a chromosomal abnormality as the
underlying defect is further substantiated by the fact that
LVHT is particularly prevalent in young patients with
chromosomal abnormalities [21].
In patients with epilepsy, an association with a trunca-
tion mutation of the KCNMB3 gene has been described
which is partly affected from the duplication on chromo-
some 3 [22]. However, consequences of the duplication
on the transcripts of this gene were not tested, and this
is why such a presumed association remains speculative.
The first CNV detected in our patient (1p12 deletion)
results in a deletion of part of the NOTCH2 gene that
can be mutated in Alagille syndrome, a multisystem dis-
order with predominantly liver-, skeletal, ophthalomolo-
gic and renal abnormalities [23]. We consider Alagille
syndrome unlikely in our patient since she did not show
any of these abnormalities, although highly variable ex-
pressivity of the affected systems has been described in
subjects with NOTCH2 mutations [24].
Conclusions
This case shows that childhood LVHT may be associated
with other cardiac abnormalities, central nervous system
disease and minor facial anomalies. Despite this complex
phenotype de novo microdeletions or microduplications
were not detected by array CGH. Further investigations,
such as whole exome sequencing, could reveal point mu-
tations and small indels as the possible cause.
Consent
The father of the patient has given his consent for the
case report to be published.
Methods
Microarray-based comparative genomic hybridization
(Array CGH)
Array CGH was performed using the 1 M oligonucleo-
tide array (SurePrint G3 Human CGH 1x 1 M micro-
array, Agilent Technologies, Santa Clara, CA). We used
female reference DNA (Human Genomic DNA female,Promega). Processing of the array was done according to
the manufacturer's instructions. Extraction of microarray
TIFF images had been done by “Feature Extraction” and
the following data analysis was done by the “DNA Ana-
lytics 4.0” software (both Agilent Technologies, Santa
Clara, CA). The following analysis settings in DNA ana-
lytics software were applied: algorithm ADM-2, filter 5
probes, log2ratio 0.29.
Quantitative real-time PCR (qPCR)
Genomic DNA samples of the index patient and her par-
ents were obtained from EDTA-blood. Amplicons were
located within the aberrant regions as detected by array
CGH and in flanking regions. Primer sequences can be
obtained upon request. qPCR was performed as previ-
ously described [20].
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